Physician profile
Peter Pastuszko
NPI 1194793448
$2,851.89
in general payments reported to CMS, 2019-2025
6 companies · $215 in 2025
The $215 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $647 · 2020: $125 · 2021: $875 · 2022: $202 · 2023: $325 · 2024: $463 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,003.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,003.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Artivion, INC. | $1,853.54 | 2019-2024 | Bioglue Surgical Adhesive, Photofix Decellularized Bovine Pericardium, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder |
| Abbott Laboratories | $427.31 | 2019-2024 | Mini Trek |
| Davol INC. | $320.09 | 2024-2025 | Progel Applicator Spray Tips, Arista Ah Flexitip |
| Baxter Healthcare | $138.74 | 2023 | Coseal |
| Lemaitre Vascular, INC. | $58.09 | 2019-2024 | Tyke, Patch, Pledget and Intracardiac |
| Scpharmaceuticals INC. | $54.12 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Pastuszko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.